Litcius/Paper detail

Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19

Kholoud F. Aliter, Rami A. Al‐Horani

2020Cardiovascular Drugs and Therapy48 citationsDOIOpen Access PDF

Topics & Concepts

ArgatrobanMedicineDiscovery and development of direct thrombin inhibitorsThrombinAntithromboticPharmacologyThrombomodulinDirect thrombin inhibitorXimelagatranBivalirudinImmunologyWarfarinInternal medicinePlateletMyocardial infarctionDabigatranPercutaneous coronary interventionAtrial fibrillationHeparin-Induced Thrombocytopenia and ThrombosisVenous Thromboembolism Diagnosis and ManagementCOVID-19 Clinical Research Studies
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19 | Litcius